,78,79,80,81,82,83 SPAG9 silencing in combination with paclitaxel treatment synergistically inhibited ovarian cancer cell viability, and SPAG9 depletion in ovarian cancer xenograft mouse models significantly reduced tumor growth.81 This evidence concerns the gene SPAG9 and neoplasm.